Polatuzumab vedotin in combination with venetoclax and rituximab for patients with R/R DLBCL
Here, we summarize results from a phase Ib/II trial assessing the safety and efficacy of polatuzumab vedotin in combination with rituximab and lenalidomide in patients with R/R DLBCL.